Antimicrobial host defense

Platelets

Volumn , Issue , 2007, Pages 727-755

  Yeaman, Michael R ^a   Bayer, Arnold S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 76649088023     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012369367-9/50802-8     Document Type: Chapter

References (281)

1. Nachum R., Watson S.W., Sullivan J.D., et al. Antimicrobial defense mechanisms in the horseshoe crab, Limulus polyphemus: Preliminary observations with heatderived extracts of Limulus amoebocyte lysate. J Invert Pathol 1980, 32:51-58.
2. Maluf N.S.R. The blood of arthropods. Quart Rev Biol 1939, 14:149-191.
3. Weksler B.B. Platelets. Inflammation: Basic principles and clinical correlates 1992, 543-557. Raven Press, New York. 2nd ed. J.I. Gallin, I.M. Goldstein, R. Snyderman (Eds.).
4. Tocantins L.M. The mammalian blood platelet in health and disease. Medicine 1938, 17:155-257.
5. White J.G. Platelet morphology and function. Hematology 1972, 1023-1039. W.J. Williams, E. Beutler, A.J. Erslev, R.W. Rundles (Eds.).
6. Marcus A.J. Platelet function. New Eng J Med 1969, 280:1213.
7. Marcus A.J. Platelet function. New Eng J Med 1969, 280:1278.
8. Marcus A.J. Platelet function. New Eng J Med 1969, 280:1330.
9. Heyssel R.M. Determination of human platelet survival utilizing 14C-labelled serotonin. J Clin Invest 1961, 40:2134-2138.
10. Murphy E.A., Robinson G.A., Rowsell A. The pattern of platelet disappearance. Blood 1967, 30:26-31.
11. Harker L.A., Finch C.A. Thrombokinetics in man. J Clin Invest 1969, 48:963-1969.
12. Booyse F., Rafelson M.E. Stable messenger RNA in the synthesis of contractile protein in human platelets. Biochem Biophys Acta 1967, 145:188-192.
13. Booyse F., Rafelson M.E. In vitro incorporation of amino acids into the contractile protein of human blood platelets. Nature 1967, 215:283-285.
14. Warshaw A.L., Laster L., Shulman N.R. Protein synthesis by human platelets. J Biol Chem 1967, 242:2094-2100.
15. Day H.J., Ang G.A.T., Holmsen H. Platelet release reaction during clotting of native human platelet rich plasma. Proc Soc Exp Med Biol 1972, 139:717-721.
16. Colman R.W. Receptors that activate platelets. Proc Soc Exp Biol Med 1991, 197:242-248.
17. MacFarlane D.E., Mills D.C.B. The effects of ATP on platelets: Evidence against the central role of released ADP in primary aggregation. Blood 1975, 46:309-314.
18. MacFarlane D.E., Walsh P.N., Mills D.C.B., et al. The role of thrombin in ADP-induced platelet aggregation and release: A critical evaluation. Br J Haematol 1975, 30:457-464.
19. Davies T.A., Fine R.E., Johnson R.J., et al. Nonage related differences in thrombin responses by platelets from male patients with advanced Alzheimer's disease. Biochem Biophys Res Comm 1993, 194:537-543.
20. Day H.J., Rao A.K. Evaluation of platelet function. Semin Hematol 1986, 23:89-101.
21. Parmentier S., Kaplan C., Catimel B., et al. New families of adhesion molecules play a vital role in platelet functions. Immunol Today 1990, 11:225-227.
22. Yeaman M.R. The role of platelets in antimicrobial host defense. Clin Infect Dis 1997, 25:951-968.
23. Yeaman M.R., Bayer A.S. Antimicrobial peptides from platelets. Drug Resistance Updates 1999, 2:116-126.
24. Bancsi M.J.L.F., Thompson J., Bertina R.M. Stimulation of monocyte tissue factor expression in an in vitro model of bacterial endocarditis. Infect Immun 1994, 62:5669-5672.
25. Drake T.A., Pang M. Staphylococcus aureus induces tissue factor expression in cultured human cardiac valve endothelium. J Infect Dis 1988, 157:749-756.
26. Drake T.A., Rodgers G.M., Sande M.A. Tissue factor is a major stimulus for vegetation formation in enterococcal endocarditis in rabbits. J Clin Invest 1984, 73:1750-1753.
27. White J.G. Views of the platelet at rest and at work. Ann NY Acad Sci 1987, 509:156-176.
28. White J.G., Sauk J.J. Microtubule coils in spread blood platelets. Blood 1984, 64:470-478.
29. Zucker M.B. The functioning of blood platelets. Sci Am 1980, 242:70-89.
30. Scheld W.M., Valone J.A., Sande M.A. Bacterial adherence in the pathogenesis of infective endocarditis: Interaction of dextran, platelets, & fibrin. J Clin Invest 1978, 61:1394-1404.
31. Durack D.T. Experimental bacterial endocarditis. IV. Structure and evolution of very early lesions. J Clin Pathol 1975, 45:81-89.
32. Calderone R.A., Rotondo M.F., Sande M.A. Candida albicans endocarditis: Ultrastructural studies of vegetation formation. Infect Immun 1978, 20:279-289.
33. Durack D.T., Beeson P.B., Petersdorf R.G. Experimental bacterial endocarditis. III. Production of progress of the disease in rabbits. Br J Exp Pathol 1973, 54:142-151.
34. Sullam P.M., Drake T.A., Sande M.A. Pathogenesis of endocarditis. Am J Med 1985, 78(suppl 6B):110-115.
35. Ferguson D.J.P., McColm A.A., Savage T.J., et al. A morphological study of experimental rabbit staphylococcal endocarditis and aortitis. I. Formation and effect of infected and uninfected vegetations on the aorta. Br J Exp Pathol 1986, 67:667-678.
36. Scheld W.M., Sande M.A. Endocarditis and intravascular infections. Principles and practice of infectious diseases 1995, 740-782. Churchill Livingstone, New York. 5th ed. G.L. Mandell, J.E. Bennet, R. Dolin (Eds.).
37. Clawson C.C. Role of platelets in the pathogenesis of endocarditis. In Infectious Endocarditis. Am Heart Assoc Monograph 1977, 52:24-27.
38. Roberts W.C., Buchbinder N.A. Right-sided valvular infective endocarditis: A clinicopathologic study of 12 necropsy patients. Am J Med 1972, 53:7-19.
39. Buchbinder N.A., Roberts W.C. Left-sided valvular infective endocarditis: A study of 45 necropsy patients. Am J Med 1972, 53:20-35.
40. Vinter D.W., Burkel W.E., Wakefield T.W., et al. Radioisotope-labeled platelet studies and infection of vascular grafts. J Vasc Surg 1984, 6:921-923.
41. Osler W. On certain problems in the physiology of the blood corpuscles. Med News 1886, 48:365-370.
42. Osler W. On certain problems in the physiology of the blood corpuscles. Med News 1886, 48:393-399.
43. Osler W. On certain problems in the physiology of the blood corpuscles. Med News 1886, 48:421-425.
44. Cheung A.L., Fischetti V.A. The role of fibrinogen in staphylococcal adherence to catheters in vitro. J Infect Dis 1990, 161:1177-1186.
45. Roberts W.C., Buchbinder N.A. Right-sided valvular infective endocarditis: A clinicopathologic study of 12 necropsy patients. Am J Med 1972, 53:7-19.
46. Piguet P.F., Vesin C., Ryser J.E., et al. An effector role for platelets in systemic and local lipopolysaccharideinduced toxicity in mice, mediated by a CD11a-and CD54adependent interaction with endothelium. Infect Immum 1993, 61:82-87.
47. Smith C.W. Leukocyte-endothelial cell interaction. Sem Hematol 1993, 30:45-55.
48. Durack D.T., Beeson P.B., Petersdorf R.G. Experimental bacterial endocarditis. III. Production of progress of the disease in rabbits. Br J Exp Pathol 1973, 54:142-151.
49. Maisch P.A., Calderone R.A. Adherence of Candida albicans to a fibrin-platelet matrix formed in vitro. Infect Immun 1980, 27:650-656.
50. Klotz S.A., Harrison J.L., Misra R.P. Aggregated platelets enhance adherence of Candida yeasts to endothelium. J Infect Dis 1989, 160:669-677.
51. Yeaman M.R., Norman D.C., Bayer A.S. Staphylococcus aureus susceptibility to thrombin-induced platelet microbicidal protein is independent of platelet adherence or aggregation in vitro. Infect Immun 1992, 60:2368-2374.
52. Sullam P.M., Valone F.H., Mills J. Mechanisms of platelet aggregation by viridans group streptococci. Infect Immun 1987, 55:1743-1750.
53. Robert R., Senet J.M., Mahaza C., et al. Molecular basis of the interaction between Candida albicans, fibrinogen, and platelets. J Mycol Med 1992, 2:19-25.
54. Herzberg M.C., Brintzenhofe K.L., Clawson C.C. Aggregation of human platelets and adhesion of. Streptococcus sanguis. Infect Immun 1983, 39:1457-1469.
55. Herzberg M.C., Gong K., MacFarlane G.D., et al. Phenotypic characterization of Streptococcus sanguis virulence factors associated with bacterial endocarditis. Infect Immun 1990, 58:515-522.
56. Nicolau D.P., Freeman C.D., Nightingale C.H., et al. Reduction of bacterial titers by low-dose aspirin in experimental aortic valve endocarditis. Infect Immun 1993, 61:1593-1595.
57. Clawson C.C., White J.G. Platelet interaction with bacteria. II. Fate of bacteria. Am J Pathol 1971, 65:381-398.
58. Rosenfeld S.I., Looney R.J., Leddy J.P. Human platelet Fc receptor of immunoglobulin G. J Clin Invest 1985, 76:2317-2322.
59. Joseph M., Aurialt C. A new function for platelets: IgE-dependent killing of schistosomes. Nature 1983, 303:810-812.
60. Bout D., Joseph M., Ponet M. Rat resistance to schistosomiasis: Platelet-mediated cytotoxicity induced by C-reactive protein. Science 1986, 231:153-156.
61. Ochenhouse C.F., Magowan C., Chulay J.D. Activation of monocytes and platelets by monoclonal anti-bodies or malaria-infected erythrocytes binding to CD36 surface receptor in vitro. J Clin Invest 1989, 84:468-475.
62. Cosgrove L.J., de Apice A.J., Haddad A., et al. CR3 receptors on platelets and it role in the prostaglandin metabolic pathway. Immunol Cell Biol 1987, 65:453-460.
63. Pancré V., Monte D., Delanoye A., et al. Interleukin-6, the main mediator of interaction between monocytes and platelets in killing of. Schistosoma mansoni. Eur Cytokine Net 1990, 1:15-19.
64. Peng J., Friese P., George J.N., et al. Alteration of platelet function in dogs mediated by interleukin-6. Blood 1994, 83:398-403.
65. Clemetson K.J., Clemetson J.M., Proudfoot A.E., et al. Functional expression of CCR1, CCR3, CCR4, and CXCR4 chemokine receptors on human platelets. Blood 2000, 96:4046-4054.
66. Bureau M.F., DeClerck F., Lefort J., et al. Thromboxane A2 accounts for bronchoconstriction, but not for platelet sequestration and microvascular albumin exchanges induced by f-met-leu-phe in the guinea pig lung. J Pharmacol Exp Ther 1992, 260:832-8840.
67. Coyle A.J., Vargaftig B.B. Animal models for investigating the allergic and inflammatory properties of platelets. Immunopharmacology of platelets 1995, 21-30. Academic Press, London. M. Joseph (Ed.).
68. Jaff M.S., McKenna D., McCann S.R. Platelet phagocytosis: A probable mechanism of thrombocytopenia in Plasmodium falciparum infection. J Clin Pathol 1985, 38:1318-1319.
69. Movat H.Z., Weiser W.J., Glynn M.F., et al. Platelet phagocytosis and aggregation. J Cell Biol 1965, 27:531-543.
70. Joseph M. Generation of free radicals by platelets. Immunopharmacology of platelets 1995, 209-225. Academic Press, London. M. Joseph (Ed.).
71. Kitagawa S., Fujisawa H., Kametani F., et al. Generation of active oxygen species in blood platelets: Spin trapping studies. Free Radical Res Commun 1992, 15:319-324.
72. Bout D., Joseph M., Ponet M. Rat resistance to schistosomiasis: Platelet-mediated cytotoxicity induced by C-reactive protein. Science 1986, 231:153-156.
73. Haque A., Cuna W., Bonnel B., et al. Platelet-mediated killing of larvae from different filarial species in the presence of Dipetalonema viteae-stimlated IgE antibodies. Parsitol Immunol 1985, 7:517-526.
74. Zucker-Franklin D., Termin C.S., Cooper M.C. Structural changes in the megakaryocytes of patients infected with the human immune deficiency virus (HIV-I). Am J Pathol 1989, 134:1295-1303.
75. Zucker-Franklin D., Seremetis S., Zheng Z.Y. Internalization of human immunodeficiency virus type I and other retroviruses by megarkaryocytes and platelets. Blood 1990, 75:1920-1923.
76. Zucker-Franklin D Platelets in viral infections. Immunopharmacology of platelets 1995, 137-149. Academic Press, London. M. Joseph (Ed.).
77. Bik T., Sarow I., Livne A. Interaction between virus and human blood platelets. Blood 1982, 482-495.
78. De Harven E., Friend C. Further electron microscopic studies of a mouse leukemia induced by cell-free filtrates. J Biophys Biochem Cytol 1960, 7:747-754.
79. Dalton A.J., Law L.W., Moloney J.B., et al. An electron microscopic study of a series of murine lymphoid neoplasms. J Natl Cancer Inst (USA) 1961, 27:747-791.
80. Terada H., Baldini M., Ebbe S., et al. Interaction of influenza virus with blood platelets. Blood 1966, 28:213-228.
81. Turpie A.G., Chernesky M.A., Larke R.P., et al. Effect of Newcastle disease virus on human or rabbit platelets: Aggregation and loss of constituents. Lab Invest 1973, 28:575-580.
82. Sakaguchi M., Sato T., Groopman J.E. Human immunodeficiency virus infection of megakaryocytic cells. Blood 1991, 78:481-485.
83. Monté D., Groux H., Raharinivo B., et al. Productive human immunodeficiency virus-1 infection of megakaryocytic cells is enhanced by tumor necrosis factorα. Blood 1992, 79:2670-2679.
84. Brown W.M., Axelrad A.A. Effect of Friend leukemia virus on megakaryocytes and platelets in mice. Int J Cancer 1976, 18:764-773.
85. Oski F.A., Naiman J.L. Effect of live measles vaccine on the platelet count. N Engl J Med 1966, 275:352-356.
86. Danon D., Jerushalmy Z., de Vries A. Incorporation of influenza virus in human blood platelets in vitro: Electron microscopic observation. Virology 1959, 9:719-722.
87. Srivastava A., Bruno E., Bridell R., et al. Parvovirus B19-induced perturbation of human megakaryocytopoiesis in vitro. Blood 1990, 76:1997-2004.
88. Myllya G., Vaheri A., Vesikari T., et al. Interaction between human blood platelets, viruses, and antibodies. IV. Post-rubella thrombocytopenic purpura and platelet aggregation by rubella antigen-antibody interaction. Clin Exp Immunol 1969, 4:323-332.
89. Dixon R., Rosse W., Ebbert L. Quantitative determination of antibody in idiopathic thrombocytopenic purpura: Correlation of serum and platelet-bound antibody with clinical response. N Engl J Med 1973, 292:230-236.
90. Lurhuma A.Z., Riccomi H., Masson P.L. The occurrence of circulating immune complexes and viral antigens in idiopathic thrombocytopenic purpura. Clin Exp Immunol 1977, 28:49-55.
91. Sissons J.G., Oldstone M.B., Schreiber R.D. Antibody-dependent activation of the alternative complement pathway by measles virus-infected cells. Proc Natl Acad Sci USA 1980, 77:559-562.
92. Boonpucknavig N., Nimmanitya S. Demonstration of dengue antibody complexes on the surface of platelets from patients with dengue hemorrhagic fever. Am J Trop Med Hyg 1979, 28:881-884.
93. Clawson C.C., White J.G. Platelet interaction with bacteria. I. Reaction phases and effects of inhibitors. Am J Pathol 1971, 65:367-380.
94. Clawson C.C. Platelet interaction with bacteria. III. Ultrastructure. Am J Pathol 1973, 70:449-472.
95. Clawson C.C., Rao G.H.R., White J.G. Platelet interaction with bacteria. IV. Stimulation of the release reaction. Am J Pathol 1975, 81:411-420.
96. Saluk-Juszczak J., Wachowicz B., Kaca W. Endotoxins stimulate generation of superoxide radicals and lipid peroxidation in blood platelets. Microbios 2000, 103:17-25.
97. Forrester L.J., Campbell B.J., Berg J.N., et al. Aggregation of platelets by Fusobacterium necrophorum. J Clin Microbiol 1985, 22:245-249.
98. Czuprynski C.J., Balish E. Interaction of rat platelets with. Listeria monocytogenes. Infect Immun 1981, 33:103-108.
99. Copley A.L., Maupin B., Balea T. The agglutinant and adhesive behaviour of isolated human and rabbit platelets in contact with various strains of mycobacteria. Acta Tubercul Scand 1959, 37:151-161.
100. Kessler C.M., Nussbaum E., Tuazon C.U. In vitro correlation of platelet aggregation with occurrence of disseminated intravascular coagulation and subacute bacterial endocarditis. J Lab Clin Med 1987, 109:647-652.
101. Timmons S., Huzoor-Akbar A., Grabarek J., et al. Mechanism of human platelet activation by endotoxic glycolipid-bearing mutant Re595 of. Salmonella minnesota. Blood 1986, 68:1015-1023.
102. Mandell G.L., Hook E.W. The interaction of platelets, Salmonella, and mouse peritoneal macrophages. Proc Soc Exp Biol Med 1969, 132:757-759.
103. Simmonet M., Triadou P., Frehel C., et al. Human platelet aggregation by Yersinia pseudotuberculosis is mediated by invasin. Infect Immun 1992, 60:366-373.
104. Herzberg M.C., Brintzenhofe K.L., Clawson C.C. Aggregation of human platelets and adhesion of. Streptococcus sanguis. Infect Immun 1983, 39:1457-1469.
105. Herzberg M.C., Brintzenhofe K.L., Clawson C.C. Cell-free released components of Streptococcus sanguis inhibit human platelet aggregation. Infect Immun 1983, 394-401.
106. Gong K., Herzberg M.C. Streptococcus sanguis expresses a 150-kilodalton two-domain adhesin: Characterization of several independent adhesin epitopes. Infect Immun 1997, 65:3815-3821.
107. Sullam P.M., Payan D.G., Dazin P.F., et al. Binding of viridans group streptococci to human platelets: A quantitative analysis. Infect Immun 1990, 58:3802-3806.
108. Bayer A.S., Sullam P.M., Ramos M., et al. Staphylococcus aureus induces platelet aggregation via a fibrinogen-dependent mechanism which is independent of principal platelet glycoprotein IIb/IIIa fibrinogen binding domains. Infect Immun 1995, 63:3634-3641.
109. Yeaman M.R., Sullam P.M., Dazin P.F., et al. Characterization of Staphylococcus aureus-platelet binding by quantitative flow cytometric analysis. J Infect Dis 1992, 166:65-73.
110. Alugupalli K.R., Michelson A.D., Barnard M.R., et al. Platelet activation by a relapsing fever spirochaete results in enhanced bacterium-platelet interaction via integrin alpha II/beta III activation. Mol Microbiol 2001, 39:330-340.
111. Siboo I.R., Cheung A.L., Bayer A.S., et al. Clumping factor A mediates binding of Staphylo coccus aureus to human platelets. Infect Immun 2001, 69:3120-3127.
112. Bensing B.A., Rubens C.E., Sullam P.M. Genetic loci of Streptoccus mitis that mediate binding to human platelets. Infect Immun 2001, 69:1373-1380.
113. Cheung A.L., Krishnan M., Jaffe E.A., et al. Fibrinogen acts as a bridging molecule in the adherence of Staphylococcus aureus to cultured human endothelial cells. J Clin Invest 1991, 87:2236-2245.
114. Clawson C.C., White J.G., Herzberg M.C. Platelet interaction with bacteria. VI. Contrasting the role of fibrinogen and fibronectin. Am J Hematol 1980, 9:43-53.
115. Toy P.T.C.Y., Lai L-W., Drake T.A., et al. Effect of fibronectin on adherence of Staphylococcus aureus to fibrin thrombi in vitro. Infect Immun 1985, 48:83-86.
116. Herrmann M., Suchard S.J., Boxer L.A., et al. Thrombospondin binds to Staphylococcus aureus and promotes staphylococcal adherence to surfaces. Infect Immun 1991, 59:271-288.
117. Hawiger J., Streackley S., Hammond D., et al. Staphylococcal-induced human platelet injury mediated by protein A and immunoglobulin G Fc receptor. J Clin Invest 1979, 64:931-937.
118. Pfueller S.L., Cosgrove L.J. Staphylococciinduced human platelet injury. Thromb Res 1980, 19:733-735.
119. Spika J.S., Peterson P.K., Wilkinson B.J., et al. Role of peptidoglycan from Staphylococcus aureus in leukopenia, thrombocytopenia, and complement activation associated with bacteremia. J Infect Dis 1982, 146:227-234.
120. Ginsberg M.H., Henson P.M. Enhancement of platelet response to immune complexes and IgG aggregates by lipid A-rich bacterial lipopolysaccharides. J Exp Med 1978, 147:207-218.
121. Sullam P.M., Jarvis G.A., Valone F.H. Role of immunoglobulin G in platelet aggregation by viridans group streptococci. Infect Immun 1988, 56:2907-2911.
122. Zimmerman T.S., Spregelberg H.L. Pneumo coccus-induced serotonin release from human platelets. J Clin Invest 1975, 56:828-834.
123. Ford I., Douglas C.W.I., Preston S.E., et al. Mechanisms of platelet aggregation by Streptococcus sanguis, a causative organism in infective endocarditis. Brit J Hematol 1993, 84:85-100.
124. Kurpiewski G.E., Forrester L.J., Campbell B.J., et al. Platelet aggregation by Streptococcus pyogenes. Infect Immun 1983, 39:704-708.
125. Johnson C.M., Bowie E.J.W. Pigs with von Willebrand disease may be resistant to experimental infective endocarditis. J Lab Clin Med 1992, 120:553-558.
126. Gong K., Wen D.Y., Ouyang T., et al. Platelet receptors for the Streptococcus sanguis adhesin-and aggregation-associated antigens are distinguished by antiidiotypical monoclonal antibodies. Infect Immun 1995, 63:3628-3633.
127. Sedwitz M.M., Hye R.J., Stabile B.E. The changing epidemiology of pseudoaneurysm: Therapeutic implications. Arch Surg 1988, 123:473-476.
128. Kaye D. The changing pattern of infective endocarditis. Am J Med 1985, 78(suppl 6B):157-162.
129. Edwards J.E. Invasive Candida infections: Evolution of a fungal pathogen. N Engl J Med 1991, 324:1060-1062.
130. Horn R., Wong B., Kiehn T.E., et al. Fungemia in a cancer hospital: Changing frequency, earlier onset, and results of therapy. Rev Infect Dis 1985, 7:646-655.
131. Maisch P.A., Calderone R.A. Role of surface mannans in the adherence of Candida albicans to fibrinplatelet clots formed in vitro. Infect Immun 1981, 32:92-97.
132. Robert R., Senet J.M., Mahaza C., et al. Molecular basis of the interaction between Candida albicans, fibrinogen, and platelets. J Mycol Med 1992, 2:19-25.
133. Christin L., Wysong D.R., Meshulam T., et al. Mechanisms and target sites of damage in killing of Candida albicans hyphae by human polymorphonuclear neutrophils. J Infect Dis 1997, 176:1567-1578.
134. Haque A., Cuna W., Bonnel B., et al. Platelet-mediated killing of larvae from different filarial species in the presence of Dipetalonema viteae-stimulated IgE antibodies. Parasite Immunol 1985, 7:517-526.
135. Pancré V., Cesbron J.Y., Auriault C., et al. IgE dependent killing of Brugia malayi microfi lariae by human platelets and its modulation by T cell products. Int Arch Allergy Appl Immunol 1988, 85:483-486.
136. Ridel P.R., Auriault C., Darcy F., et al. Protective role of IgE in immunocompromised rat toxoplasmosis. J Immunol 1988, 141:978-983.
137. Yong E.C., Chi E.Y., Fritsche T.R., et al. Human platelet-mediated cytotoxicity against Toxoplasma gondii: Role of thromboxane. J Exp Med 1991, 173:65-78.
138. Viens P., Dubois R., Kingshavn P.A.L. Platelet activity in immune lysis of. Trypanosoma musculi J Parasitol 1983, 13:527-530.
139. Umekita L.F., Mota I. In vitro lysis of sensitized Trypanosoma cruzi by platelets: Role of C3b receptors. Parasite Immunol 1989, 11:561-563.
140. Peyron F., Polack B., Lamotte D., et al. Plasmodium falciparum growth inhibition by human platelets in vitro. Parasitol 1989, 99:317-322.
141. Capron M., Jouault T., Prin L., et al. Functional study of a monoclonal antibody to IgE Fc receptor (FcE R2) of eosinophils, platelets, and macrophages. J Exp Med 1986, 164:72-89.
142. Verwaerde C., Joseph M., Capron M., et al. Fuctional properties of a rat monoclonal IgE antibody specific for. Schistosoma mansoni. J Immunol 1987, 138:4441-4446.
143. Monté D., Wietzerbin J., Pancré V., et al. Identification and characterization of a functional receptor for interferonγ on a megakaryocytic cell line. Blood 1991, 78:2062-2069.
144. Pancré V., Auriault C., Joseph M., et al. A suppressive lymphokine of platelet cytotoxic function. J Immunol 1986, 137:585-591.
145. Fodor J. Die fahigkeit des blutes bakterien zu vernichten. Dtsch Med Wochenschr 1887, 13:745-747.
146. Gengou O. De l'origine de l'axenine de serums normaux. Ann Inst Pasteur 1901, 15:232-245. Paris.
147. Hirsch J.G. Comparative bactericidal activities of blood serum and plasma serum. J Exp Med 1960, 112:15-22.
148. Jago R., Jacox R.F. Cellular source and character of a heat-stable bactericidal property associated with rabbit and rat platelets. J Exp Med 1961, 113:701-709.
149. Weksler B.B. Induction of bactericidal activity in human platelets. Clin Res 1971, 19:434-435.
150. Kahn R.A., Flinton L.J. The relationship between platelets and bacteria. Blood 1974, 44:715-721.
151. Miragliotta G., Lafata M., Jirilla E. Antibacterial activity mediated by human platelets. Agents Actions 1988, 25:401-406.
152. Carroll S.F., Martinez R.J. Antibacterial peptide from normal rabbit serum. I. Isolation from whole serum, activity, and microbiologic spectrum. Biochem 1981, 20:5973-5981.
153. Carroll S.F., Martinez R.J. Antibacterial peptide from normal rabbit serum. II. Compositional microanalysis. Biochem 1981, 20:5981-5987.
154. Carroll S.F., Martinez R.J. Antibacterial peptide from normal rabbit serum. III. Inhibition of microbial electron transport. Biochem 1981, 20:5988-5994.
155. Myrvik Q.N. Serum bactericidins active against Gram-positive bacteria. Ann NY Acad Sci 1956, 66:391-400.
156. Myrvik Q.N., Leake E.S. Studies on antibacterial factors in mammalian tissues and fluids. IV. Demonstration of two non-dialyzable components in the serum bactericidin system for Bacillus subtilis. J Immunol 1960, 84:247-250.
157. Johnson F.B., Donaldson D.M. Purification of staphylocidal β-lysin from rabbit serum. J Bacteriol 1968, 96:589-595.
158. Donaldson D.M., Tew J.G. β-lysin of platelet origin. Bacteriol Rev 1977, 41:501-512.
159. Weksler B.B., Nachman R.L. Rabbit platelet bactericidal protein. J Exp Med 1971, 134:1114-1130.
160. Tew J.G., Roberts R.R., Donaldson D.M. Release of β-lysin from platelets by thrombin and by a factor produced in heparinized blood. Infect Immun 1974, 9:179-186.
161. Dankert J. Role of platelets in early pathogenesis of viridans group streptococcal endocarditis. Ph.D. Dissertation 1988, University of Groningen, The Netherlands.
162. Dankert J., van der Werff J., Zaat S.A.J., et al. Involvement of bactericidal factors from thrombin-stimulated platelets in clearance of adherent viridans streptococci in experimental infective endocarditis. Infect Immun 1995, 63:663-671.
163. Darveau R.P., Blake J., Seachord C.L., et al. Peptide related to the carboxy-terminus of human platelet factor IV with antibacterial activity. J Clin Invest 1992, 90:447-455.
164. Yeaman M.R., Puentes S.M., Norman D.C., et al. Partial Purification and staphylocidal activity of thrombin-induced platelet microbicidal protein. Infect Immun 1992, 60:1202-1209.
165. Yeaman M.R., Tang Y-Q., Shen A.J., et al. Puri-fication and in vitro activities of rabbit platelet microbicidal proteins. Infect Immun 1997, 65:1023-1031.
166. Yeaman M.R., Ibrahim A., Filler S.G., et al. Thrombin-induced rabbit platelet microbicidal protein is fungicidal in vitro. Antimicrob Agents Chemother 1993, 37:546-553.
167. Ganz T., Selsted M.E., Lehrer R.I. Defensins. Eur J Haematol 1990, 44:1-8.
168. Azizi N., Li C., Shen A.J., et al. Staphylococcus aureus elicits release of platelet microbicidal proteins in vitro. Abstract no. 866 1996.
169. Bayer A.S., Ramos M.D., Menzies B.E., et al. Hyperproduction of alpha-toxin by Staphylococcus aureus results in paradoxically reduced virulence in experimental endocarditis: A host defense role for platelet microbicidal proteins. Infect Immun 1997, 65:4652-4660.
170. Tang Y.Q., Yeaman M.R., Selsted M.E. Antimicrobial proteins from human platelets. Infect Immun 2002, 70:6524-6533.
171. Tang Y.Q., Yeaman M.R., Selsted M.E. Microbicidal and synergistic activities of human platelet factor-4 (hPF-4) and connective tissue activating peptide-3 (CTAP-3). Blood 1995, 86:556a.
172. Krijgsveld J., Zaat S.A., Meeldijk J., et al. Thrombocidins, microbicidal proteins from human blood platelets, are C-terminal deletion products of CXC chemokines. J Biol Chem 2000, 275:20374-20381.
173. Zasloff M. Antibiotic peptides as mediators of innate immunity. Curr Opin Immunol 1992, 4:3-8.
174. Bowman H.G. Antibacterial peptides: Key components in immunity. Cell 1991, 65:205-211.
175. Taylor R. Drugs R Us: Finding new antibiotics at the endogenous pharmacy. J NIH Res 1993, 5:59-63.
176. Trier D.A., Bayer A.S., Yeaman M.R. Staphylococcus aureus elicits antimicrobial responses from platelets via an ADP-dependent pathway. 40th ICAAC, American Society for Microbiology 2000, Abstract 1010.
177. Sharma A., Novak E.K., Sojar H.T., et al. Porphyromonas gingivalis platelet aggregation activity: Outer membrane vesicles are potent activators of murine platelets. Oral Microbiol Immunol 2000, 15:393-396.
178. Srichaikul T., Nimmanitya S., Sripaisarn T., et al. Platelet function during acute phase of dengue hemorrhagic fever. Southeast Asian J Trop Med Pub Health 1989, 20:19-25.
179. Lorenz R., Brauer M. Platelet factor 4 (PF4) in septicaemia. Infection 1988, 16:273-276.
180. Mezzano S., Burgos M.E., Ardiles L., et al. Glomerular localization of platelet factor 4 in streptococcal nephritis. Nephron 1992, 61:58-63.
181. Yamamoto Y., Klein T.W., Friedman H. Involvement of mannose receptor in cytokine interleukin-1 beta (IL-1 beta) , IL-6, and granulocyte macrophage colony stimulating factor responses, but not in chemokine macrophage inflammatory protein-1 beta (MIP-1 beta) , MIP-2, and KC responses, caused by attachment of Candida albicans to macrophages. Infect Immun 1997, 65:1077-1082.
182. Essien E.M., Ebhota M.I. Platelet secretory activities in acute malaria ( Plasmodium falciparum) infection. Acta Haematol 1983, 70:183-188.
183. Wilson M., Blum R., Dandona P., et al. Effects in humans of intravenously administered endotoxin on soluble cell-adhesion molecule and inflammatory markers: A model of human diseases. Clin Exp Pharmacol Physiol 2001, 28:376-380.
184. Yeaman M.R., Bayer A.S., Koo S.P., et al. Platelet microbicidal proteins and neutrophil defensin disrupt the Staphylococcus aureus cytoplasmic membrane by distinct mechanisms of action. J Clin Invest 1998, 101:178-187.
185. Koo S.P., Bayer A.S., Sahl H.G., et al. Staphylocidal action of thrombin-induced platelet microbicidal protein is not solely dependent on transmembrane potential. Infect Immun 1996, 64:1070-1074.
186. Wu T.M., Yeaman M.R., Nast C., et al. Ultrastructural evidence that platelet microbicidal protein (PMP) targets the bacterial cell membrane. 96th General Meeting of the American Society for Microbiology 1996, Abstract no. A72.
187. Xiong Y.Q., Yeaman M.R., Bayer A.S. In vitro antibacterial activities of platelet microbicidal protein and neutrophil defensin against Staphylococcus aureus are influenced by antibiotics differing in mechanism of action. Antimicrob Agents Chemother 1999, 43:1111-1117.
188. Koo S.P., Yeaman M.R., Bayer A.S. Staphylocidal action of thrombin-induced platelet microbicidal protein is influenced by microenvironment and target cell growth phase. Infect Immun 1996, 64:3758-3764.
189. Koo S.P., Bayer A.S., Kagan B.L., et al. Membrane permeabilization by thrombin-induced PMP-1 is modulated by transmembrane voltage polarity and magnitude. Infect Immun 1999, 67:2475-2481.
190. Koo S.P., Yeaman M.R., Bayer A.S. Cell membrane is a principal target for the staphylocidal action of platelet microbicidal protein. 34th Annual Meeting of the Infectious Diseases Society of America 1996, Abstract no. 171.
191. Xiong Y.Q., Yeaman M.R., Bayer A.S. Thrombin- induced platelet microbicidal proteins (tPMPs) inhibit macromolecular synthesis in Staphylococcus aureus. 100th General Meeting of the American Society for Microbiology 2000, Abstract A111.
192. Mercier R.C., Rybak M.J., Bayer A.S., et al. Influence of platelets and platelet microbicidal protein susceptibility on the fate of Staphylococcus aureus in an in vitro model of infective endocarditis. Infect Immun 2000, 68:4699-4705.
193. Asensi V., Fierer J. Synergistic effect of human lysozyme plus ampicillin or β-lysin on the killing of Listeria monocytogenes. J Infect Dis 1991, 163:574-578.
194. Yeaman M.R., Norman D.C., Bayer A.S. Platelet microbicidal protein enhances antibiotic-induced killing of and post-antibiotic effect in Staphylococcus aureus. Antimicrob Agents Chemother 1992, 36:1665-1670.
195. Dhawan V.K., Yeaman M.R., Bayer A.S. Influence of in vitro susceptibility phenotype against thrombininduced platelet microbicidal protein on treatment and prophylaxis outcomes of experimental Staphylococcus aureus endocarditis. J Infect Dis 1999, 180:1561-1568.
196. Dhawan V.K., Bayer A.S., Yeaman M.R. Thrombin-induced platelet microbicidal protein susceptibility phenotype Influences the outcome of oxacillin prophylaxis and therapy of experimental Staphylococcus aureus endocarditis. Antimicrob Agents Chemother 2000, 44:3206-3209.
197. Yeaman M.R., Sullam P.M., Dazin P.F., et al. Platelet microbicidal protein alone and in combination with antibiotics reduces Staphylococcus aureus adherence to platelets in vitro. Infect Immun 1994, 62:3416-3423.
198. Yeaman M.R., Sullam P.M., Dazin P.F., et al. Fluconazole and platelet microbicidal protein inhibit Candida adherence to platelets in vitro. Antimicrob Agents Chemother 1994, 38:1460-1465.
199. Filler S.G., Joshi M., Phan Q.T., et al. Platelets protect vascular endothelial cells from injury due to Candida albicans Abstract 2163. 39th ICAAC Meeting, American Society for Microbiology 1999.
200. Polley M.J., Nachman R.L., Weksler B.B. Human complement in the arachidonic acid transformation pathway in platelets. J Exp Med 1981, 153:257-268.
201. Polley M.J., Nachman R.L. Human platelet activation by C3a and C3a des-arg. J Exp Med 1983, 158:603-615.
202. Zimmerman T.S., Kolb W.P. Human plateletinitiated formation and uptake of the C5-C9 complex of human complement. J Clin Invest 1976, 57:203-211.
203. Weksler B.B., Coupal C.E. Platelet dependent generation of chemotactic activity in serum. J Exp Med 1973, 137:1419-1429.
204. Hansch G.M., Gemsa D., Resch K. Induction of prostanoid synthesis in human platelets by the late complement components C5b-C9 and channel forming antibiotic nystatin: Inhibition of the reacylation of liberated acrachidonic acid. J Immunol 1985, 135:1320-1324.
205. Simpson R.M., Prancan A., Izzi J.M., et al. Generation of thromboxane A2 and aorta-contracting activity from platelets stimulated with modified C-reactive protein. Immunol 1982, 47:193-202.
206. Henson P.M., Ginsberg M.H. Immunological reactions of platelets. Platelets in biology and pathology 1981, 2:265-308. Elsevier, Amsterdam. J.L. Gordon (Ed.).
207. Pancré V., Joseph M., Cesbron J.Y., et al. Induction of platelet cytotoxic functions by lymphokines: Role of interferon gamma. J Immunol 1987, 138:4490-4495.
208. Damonville M., Wietzerbin J., Pancré V., et al. Recombinant tumor necrosis factors mediate platelet cytotoxicity to Schistosoma mansoni larvae. J Immunol 1988, 140:3962-3965.
209. Kenney D.M., Davis A.E. Association of alternative complement pathway components with human blood platelets: Secretion and localization of factor D and beta 1H globin. Clin Immunol Immunopathol 1981, 21:351-363.
210. Zucker M.B., Grant R.A., Alper C.A., et al. Requirement for complement components and fibrinogen in the zymosan-induced release reaction of human blood platelets. J Immunol 1974, 113:1744-1755.
211. Devine D.V., Siegel R.S., Rosse W.F. Interactions of the platelets in paryoxysmal nocturmal hemoglobinuria with complement. J Clin Invest 1987, 79:131-137.
212. Nguyen T., Ghebrehiwet B., Peerschke E.I. Staphylococcus aureus protein A recognizes platelet gC1qR/ p33: A novel mechanism for staphylococcal interactions with platelets. Infect Immun 2000, 68:2061-2068.
213. Clark-Lewis I., Dewald B., Geiser T., et al. Platelet factor-4 binds to interleukin-8 receptors and activates neutrophils when its N-terminus is modified with Glu-Leu-Arg. Proc Natl Acad Sci USA 1993, 90:3574-3577.
214. Drake W.T., Lopes N.N., Fenton J.W., II et al. Thrombin enhancement of interleukin-1 and tumor necrosis factorα induced polymorphonuclear leukocyte migration. Lab Invest 1992, 67:617-627.
215. Schroder J.M., Sticherling M., Persoon N.L., et al. Identification of a novel platelet-derived neutrophilchemotactic polypeptide with structural homology to platelet factor-4. Biochem Biophys Res Comm 1990, 172:898-904.
216. Schall T.J., Bacon K., Toy K.J., et al. Selective attraction of monocytes and T-lymphocytes of the memory phenotype by cytokine RANTES. Nature 1990, 347:669-671.
217. Deuel T.F., Senior R.M., Chang D., et al. Platelet factor-4 is chemotactic for neutrophils and monocytes. Proc Natl Acad Sci USA 1981, 78:4548-4587.
218. Tzeng D.Y., Deuel T.F., Huang J.S., et al. Plateletderived growth factor promotes polymorphonuclear leukocyte activation. Blood 1985, 4:1123-1128.
219. Nachman R.L., Weksler B.B. The platelet as an inflammatory cell. Ann NY Acad Sci 1972, 201:131-137.
220. Lellouch-Tubiana A., Lefort J., Simon M-T., et al. Eosinophil recruitment into guinea pig lungs after PAFacether and allergen administration: Modulation by prostacyclin, platelet depletion, and selective antagonists. Am Rev Respir Dis 1988, 137:948-954.
221. Jungi T.W., Spycher M.O., Nydegger V.E., et al. Platelet-leukocyte interactions: Selective binding of thrombin-stimulated platelets to human monocytes, polymorphonuclear leukocytes and related cell lines. Blood 1986, 67:629-636.
222. Silverstein R., Nachman R.L. Thrombospondin mediates the interaction of stimulated platelets with monocytes. J Clin Invest 1987, 79:867-874.
223. Burns G.F., Cosgrove L., Triglia T., et al. The IIb-IIIa glycoprotein complex that mediates platelet aggregation is directly implicated in leukocyte adhesion. Cell 1986, 45:269-280.
224. Simon D.I., Chen Z., Xu H., et al. Platelet glycoprotein ibalpha is a counterreceptor for the leukocyte integrin Mac-1 (CD11b/CD18). J Exp Med 2000, 192:193-204.
225. Clark R.A., Klebanoff S.J. Myeloperoxidasemediated platelet release reaction. J Clin Invest 1979, 63:177-183.
226. Mehta P., Mehta J., Lawson D. Leukotrienes potentiate the effects of epinephrine and thrombin on human platelet-aggregation. Thromb Res 1986, 41:731-738.
227. Schwartz B.F., Monroe M.C. Human platelet aggregation is initiated by peripheral blood mononuclear cells exposed to bacterial lipopolysaccharide in vitro. J Clin Invest 1986, 78:1136-1141.
228. Boogaerts M.A., Yamada O., Jacob H.S., et al. Enhancement of granulocyte-endothelial cell adherence and granulocyte-induced cytotoxicity by platelet release products. Proc Natl Acad Sci USA 1982, 79:7019-7023.
229. Spagnuolo P.J., Ellner J.J., Hassid A. Thromboxane A2 mediates augmented polymorphonuclear leukocyte adhesiveness 1980.
230. Wu T., Yeaman M.R., Bayer A.S. In vitro resistance to platelet microbicidal protein correlates with endocarditis source among staphylococcal isolates. Antimicrob Agents Chemother 1994, 38:729-732.
231. Yeaman M.R., Soldan S.S., Ghannoum M., et al. Resistance to platelet microbicidal protein results in the increased severity of experimental Candida albicans endocarditis. Infect Immun 1996, 64:1379-1384.
232. Dhawan V.K., Bayer A.S., Yeaman M.R. In vitro resistance to thrombin-induced platelet microbicidal protein is associated with enhanced progression and hematogenous dissemination in experimental Staphylococcus aureus infective endocarditis. Infect Immun 1998, 66:3476-3479.
233. Fowler V.G., McIntyre L.M., Yeaman M.R., et al. In vitro resistance to thrombin-induced platelet microbicidal protein in isolates of Staphylococcus aureus from endocarditis patients correlates with an intravascular device source. J Infect Dis 2000, 182:1251-1254.
234. Fields P.L., Groisman E.A., Heffron F. A Salmonella locus that controls resistance to micro-bicidal proteins from phagocytic cells. Science 1989, 243:1059-1062.
235. Groisman E.A., Parra-Lopez C., Salcedo M., et al. Resistance to host antimicrobial peptides in necessary for Salmonella virulence. Proc Natl Acad Sci USA 1992, 89:11939-11943.
236. Meyer M.W., Gong K., Herzberg M.C. Streptococcus sanguis-induced platelet clotting in rabbits and hemodynamic and cardiopulmonary consequences. Infect Immun 1998, 66:5906-5914.
237. Sullam P.M., Frank U., Yeaman M.R., et al. Effect of thrombocytopenia on the early course of streptococcal endocarditis. J Infect Dis 1993, 168:910-914.
238. Viscoli C., Bruzzi P., Castagnola E., et al. Factors associated with bacteraemia in febrile, granulocytopenic patients: The International Antimicrobial Therapy Cooperative Group (IATCG) of the European Organization for Research and Treatment of Cancer (EORTC). Eur J Cancer 1994, 30:430-437.
239. Feldman C., Kallenbach J.M., Levy H., et al. Comparison of bacteraemic community-acquired lobar pneumonia due to Streptococcus pneumoniae and Klebsiella pneumoniae in an intensive care unit. Respiration 1991, 58:265-270.
240. Kirkpatrick B., Reeves D.S., MacGowan A.P. A review of the clinical presentation, laboratory features, antimicrobial therapy and outcome of 77 episodes of pneumococcal meningitis occurring in children and adults. J Infect 1994, 29:171-182.
241. Chang F.Y., Singh N., Gayowski T., et al. Thrombocytopenia in liver transplant recipients: Predictors, impact on fungal infections, and role of endogenous thrombopoietin. Transplantation 2000, 69:70-75.
242. Korzweniowski O.M., Scheld W.M., Bithell T.C., et al. The effect of aspirin on the production of experimental Staphylococcus aureus endocarditis [abstract]. Program Abstracts of the 19th Interscience Conference on Antimicrobial Agents and Chemotherapy (Boston) 1979, American Society for Microbiology, Washington, DC.
243. Berney P., Francioli P. Successful prophylaxis of experimental streptococcal endocarditis with single-dose amoxicillin administered after bacterial challenge. J Infect Dis 1990, 161:281-285.
244. Yersin B.R., Glauser M.P., Freedman L.R. Effect of nitrogen mustard on natural history of right-sided streptococcal endocarditis in rabbits: Role for cellular host defenses. Infect Immun 1982, 35:320-325.
245. Nicolau D.P., Freeman C.D., Nightingale C.H., et al. Reduction of bacterial titers by low-dose aspirin in experimental aortic valve endocarditis. Infect Immun 1993, 61:1593-1595.
246. Kupferwasser L.I., Yeaman M.R., Shapiro S.M., et al. Acetylsalicylic acid reduces vegetation bacterial density, hematogenous bacterial dissemination, and frequency of embolic events in experimental Staphylococcus aureus endocarditis through antiplatelet and antibacterial effects. Circulation 1999, 99:2791-2797.
247. Sullam P.M., Bayer A.S., Foss W.M., et al. Diminished platelet binding in vitro by Staphylococcus aureus is associated with reduced virulence in a rabbit model of infective endocarditis. Infect Immun 1996, 64:4915-4921.
248. Mavrommatis A.C., Theodoridis T., Orfanidou A., et al. Coagulation system and platelets are fully activated in uncomplicated sepsis. Crit Care Med 2000, 28:451-457.
249. Youssefian T., Drouin A., Masse J.M., et al. Host defense role of platelets: Engulfment of HIV and Staphylococcus aureus occurs in a specific subcellular compartment and is enhanced by platelet activation. Blood 2002, 99:4021-4029.
250. Siboo I.R., Chambers H.F., Sullam P.M. Role of SraP, a serine-rich surface protein of Staphylococcus aureus in binding to human platelets. Infect Immun 2005, 73:2273-2280.
251. Niemann S., Spehr N., Van Aken H., et al. Soluble fibrin is the main mediator of Staphylococcus aureus adhesion to platelets. Circulation 2004, 110:193-200.
252. Herrmann M., Lai Q.J., Albrecht R.M., et al. Adhesion of Staphylococcus aureus to surface-bound platelets: Role of fibrinogen-fibrin and platelet ligands. J Infect Dis 1993, 167:312-322.
253. Hermann M., Jaconi M.E., Dahlgren C., et al. Neutrophil bactericidal activity against Staphylococcus aureus adherent on biological surfaces: Surface-bound extracellular matrix proteins activate intracellular killing by oxygen-dependent and-independent mechanisms. J Clin Invest 1990, 86:942-951.
254. Loughman A., Fitzgerald J.R., Brennan M.P., et al. Roles for fibrinogen, immunoglobulin and complement in platelet activation promoted by Staphylococcus aureus clumping factor A. Mol Microbiol 2005, 57:804-818.
255. Turner R.B., Liu L., Sazonova I.Y., et al. Structural elements that govern substrate specificity of the clot-dissolving enzyme plasmin. J Biol Chem 2002, 277:33068-33074.
256. Sieprawska-Lupa M., Mydel P., Krawczyk K., et al. Degradation of human antimicrobial peptide LL-37 by Staphylococcus aureus-derived proteinases. Anti microb Agents Chemother 2004, 48:4673-4679.
257. Yeaman M.R., Yount N.Y. Code among chaos: Immunorelativity and the AEGIS model of antimicrobial peptides. ASM News 2005, 71:21-27.
258. Klinger Jelkmann W. Role of blood platelets in infection and inflammation. J Interferon Cytokine Res 2002, 22:913-922.
259. Yeaman M.R., Bayer A.S. Staphylococcus aureus, platelets, and the heart. Current Infect Dis Reports 2000, 2:281-298.
260. Yeaman M.R. Antimicrobial peptides from platelets in defense against cardiovascular infections. Mammalian host defense peptides 2004, 279-322. Adv Mol Cell Micro, Cambridge University Press. D.A. Devine, R.E. W. Hancock (Eds.).
261. Yount N.Y., Gank K.D., Xiong Y.Q., et al. Platelet microbicidal protein-1: Structural themes of a multifunctional antimicrobial peptide. Antimicrob Agents Chemother 2004, 48:4395-4404.
262. Cole A.M., Ganz T., Liese A.M., et al. Cutting edge: IFN-inducible ELR-CXC chemokines display defensin-like antimicrobial activity. J Immunol 2001, 167:623-627.
263. Yang D., Chen Q., Hoover D.M., et al. Many chemokines including CCL20/MIP-3α display antimicrobial activity. J Leukoc Biol 2003, 74:448-455.
264. Yount N.Y., Yeaman M.R. Multidimensional signatures in antimicrobial peptides. Proc Natl Acad Sci USA 2004, 101:7363-7368.
265. Zaiou M., Nizet V., Gallo R.L. Antimicrobial and protease inhibitory functions of the human cathelicidin (hCAP18/LL-37) prosequence. J Invest Dermatol 2003, 120:810-816.
266. Xiong Y.Q., Mukhopadhyay K., Yeaman M.R., et al. Functional interrelationships between cell membrane and cell wall in antimicrobial peptide-mediated killing of Staphylococcus aureus. Anti microb Agents Chemother 2005, 49:3114-3121.
267. Mukhopadhyay K., Whitmire W., Xiong Y.Q., et al. In vitro resistance of Staphylococcus aureus to thrombininduced platelet microbicidal protein is associated with alterations in cytoplasmic membrane fluidity, fatty acid and phospholipids composition, and phospholipids asymmetry. 105th American Society for Microbiology 2005, Abstract A-002.
268. Weidenmaier C., Peschel A., Xiong Y.Q., et al. Lack of wall teichoic acids in Staphylococcus aureus leads to reduced interactions with endothelial cells and to attenuated virulence in a rabbit model of endocarditis. J Infect Dis 2005, 191:1771-1777.
269. Kristian S.A., Durr M., Van Strijp J.A., et al. MprF-mediated lysinylation of phospholipids in Staphylococcus aureus leads to protection against oxygen-independent neutrophil killing. Infect Immun 2003, 71:546-549.
270. Xiong Y.Q., Bayer A.S., Yeamanm M.R. Inhibition of Staphylococcus aureus intracellular macromolecular synthesis by thrombin-induced platelet microbicidal proteins. J Infect Dis 2002, 185:348-356.
271. Xiong Y.Q., Bayer A.S., Yeaman M.R., et al. Impact of sarA and agr in Staphylococcus aureus upon fibronectin-binding protein A gene expression and fibronectin adherence capacity in vitro and in experimental infective endocarditis. Infect Immun 2004, 72:1832-1836.
272. Sakoulas G., Eliopoulos G.M., Fowler V.G., et al. Staphylococcus aureus accessory gene regulator (agr) dysfunction and vancomycin exposure are associated with autolysin defect, glycopeptide intermediate susceptibility (GISA) , and reduced antimicrobial peptide susceptibility phenotypes in vitro. Antimicrob Agents Chemother 2005, 49:2687-2692.
273. Ginsburg I. The biochemistry of bacteriolysis: Facts, paradoxes, and myths. Microbiol Sci 1988, 5:137-142.
274. Yeaman M.R., Gank K.D., Bayer A.S., et al. Synthetic peptides that exert antimicrobial activities in whole blood and blood-derived matrices. Antimicro Agents Chemother 2002, 46:3883-3891.
275. Mercier R.C., Dietz R.M., Mazzola J.L., et al. Beneficial Influence of platelets on antibiotic efficacy in an in vitro model of Staphylococcus aureus endocarditis. Antimicrob Agents Chemother 2004, 48:2551-2557.
276. Cocchi F., DeVico A.L., G-Demo A., et al. Identi-fication of RANTES, MIP-1α, and MIP-1β as the major HIV-suppressive factors produced by CD8+ T cells. Science 1995, 270:1811-1815.
277. Oppenheim J.J., Yang D. Alarmins: Chemotactic activators of immune responses. Curr Opin Immunol 2005, 17:359-365.
278. Fowler V.G., Sakoulas G., McIntyre L.M., et al. Persistent bacteremia due to methicillin-resistant Staphylococcus aureus infection is associated with agr dysfunction and low-level in vitro resistance to thrombin-induced platelet microbicidal protein. J Infect Dis 2004, 190:1140-1149.
279. Kupferwasser L.I., Yeaman M.R., Shapiro S.M., et al. In vitro susceptibility to thrombin-induced platelet microbicidal protein is associated with reduced disease progression and complication rates in experimental Staphylococcus aureus endocarditis: Microbiol ogical, histopatho-logic, and echocardiographic analyses. Circulation 2002, 105:746-752.
280. Kupferwasser L.I., Yeaman M.R., Nast C.C., et al. Salicylic acid attenuates virulence in endovascular infections by targeting global regulatory pathways in. Staphylococcus aureus. J Clin Invest 2003, 112:222-233.
281. Yeaman M.R., Cheng D., Desai B., et al. Susceptibility to thrombin-induced platelet microbicidal protein is associated with increased fluconazole efficacy in experimental Candida albicans endocarditis. Antimicrob Agents Chemother 2004, 48:3051-3056.